It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The establishment of robust human brain organoids to model cerebellar diseases is essential to study new therapeutic strategies for cerebellum-associated disorders. Machado-Joseph disease (MJD) is a cerebellar hereditary neurodegenerative disease, without therapeutic options able to prevent the disease progression. In the present work, control and MJD induced-pluripotent stem cells were used to establish human brain organoids. These organoids were characterized regarding brain development, cell type composition, and MJD-associated neuropathology markers, to evaluate their value for cerebellar diseases modeling. Our data indicate that the organoids recapitulated, to some extent, aspects of brain development, such as astroglia emerging after neurons and the presence of ventricular-like zones surrounded by glia and neurons that are found only in primate brains. Moreover, the brain organoids presented markers of neural progenitors proliferation, neuronal differentiation, inhibitory and excitatory synapses, and firing neurons. The established brain organoids also exhibited markers of cerebellar neurons progenitors and mature cerebellar neurons. Finally, MJD brain organoids showed higher ventricular-like zone numbers, an indication of lower maturation, and an increased number of ataxin-3-positive aggregates, compared with control organoids. Altogether, our data indicate that the established organoids recapitulate important characteristics of human brain development and exhibit cerebellar features, constituting a resourceful tool for testing therapeutic approaches for cerebellar diseases.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 University of Coimbra, CNC-Center for Neurosciences and Cell Biology, Coimbra, Portugal (GRID:grid.8051.c) (ISNI:0000 0000 9511 4342); University of Coimbra, CIBB-Center for Innovative Biomedicine and Biotechnology, Coimbra, Portugal (GRID:grid.8051.c) (ISNI:0000 0000 9511 4342)
2 University of Coimbra, CNC-Center for Neurosciences and Cell Biology, Coimbra, Portugal (GRID:grid.8051.c) (ISNI:0000 0000 9511 4342); University of Coimbra, CIBB-Center for Innovative Biomedicine and Biotechnology, Coimbra, Portugal (GRID:grid.8051.c) (ISNI:0000 0000 9511 4342); University of Coimbra, Institute for Interdisciplinary Research, Coimbra, Portugal (GRID:grid.8051.c) (ISNI:0000 0000 9511 4342)
3 University of Minho, ICVS-Life and Health Sciences Research Institute, Braga, Portugal (GRID:grid.10328.38) (ISNI:0000 0001 2159 175X); University of Minho, CEB-Center of Biological Engineering, Braga, Portugal (GRID:grid.10328.38) (ISNI:0000 0001 2159 175X)
4 University of Coimbra, CNC-Center for Neurosciences and Cell Biology, Coimbra, Portugal (GRID:grid.8051.c) (ISNI:0000 0000 9511 4342); University of Coimbra, CIBB-Center for Innovative Biomedicine and Biotechnology, Coimbra, Portugal (GRID:grid.8051.c) (ISNI:0000 0000 9511 4342); University of Coimbra, Faculty of Pharmacy, Coimbra, Portugal (GRID:grid.8051.c) (ISNI:0000 0000 9511 4342)